share_log

Analysts Are More Bearish On Guizhou Zhenhua E-chem Inc. (SHSE:688707) Than They Used To Be

Analysts Are More Bearish On Guizhou Zhenhua E-chem Inc. (SHSE:688707) Than They Used To Be

分析師對貴州振華電子化工股份有限公司(上海證券交易所代碼:688707)的看跌程度比以往任何時候都更加看跌
Simply Wall St ·  03/07 06:17

One thing we could say about the analysts on Guizhou Zhenhua E-chem Inc. (SHSE:688707) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forecasts for the organization. Revenue and earnings per share (EPS) forecasts were both revised downwards, with analysts seeing grey clouds on the horizon.

關於貴州振華電子化工股份有限公司(SHSE: 688707)的分析師,我們可以說一件事——他們並不樂觀,他們剛剛對該組織的短期(法定)預測進行了重大負面修正。收入和每股收益(EPS)的預測均向下修正,分析師認爲灰雲即將出現。

After the downgrade, the consensus from Guizhou Zhenhua E-chem's three analysts is for revenues of CN¥6.4b in 2024, which would reflect a measurable 7.6% decline in sales compared to the last year of performance. Per-share earnings are expected to surge 212% to CN¥0.63. Previously, the analysts had been modelling revenues of CN¥13b and earnings per share (EPS) of CN¥1.97 in 2024. Indeed, we can see that the analysts are a lot more bearish about Guizhou Zhenhua E-chem's prospects, administering a pretty serious reduction to revenue estimates and slashing their EPS estimates to boot.

下調評級後,貴州振華電子的三位分析師一致認爲,2024年的收入爲64億元人民幣,這將反映出與去年業績相比銷售額可衡量的7.6%下降。預計每股收益將激增212%,至0.63元人民幣。此前,分析師一直在模擬2024年的收入爲130億元人民幣,每股收益(EPS)爲1.97元人民幣。事實上,我們可以看出,分析師對貴州振華電子化學的前景更加悲觀,他們大幅下調了收入預期,並下調了每股收益預期。

earnings-and-revenue-growth
SHSE:688707 Earnings and Revenue Growth March 6th 2024
SHSE: 688707 收益和收入增長 2024 年 3 月 6 日

The consensus price target fell 7.5% to CN¥27.93, with the weaker earnings outlook clearly leading analyst valuation estimates.

共識目標股價下跌7.5%,至27.93元人民幣,疲軟的盈利前景顯然領先於分析師的估值預期。

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Guizhou Zhenhua E-chem's past performance and to peers in the same industry. We would highlight that sales are expected to reverse, with a forecast 7.6% annualised revenue decline to the end of 2024. That is a notable change from historical growth of 35% over the last five years. By contrast, our data suggests that other companies (with analyst coverage) in the same industry are forecast to see their revenue grow 19% annually for the foreseeable future. So although its revenues are forecast to shrink, this cloud does not come with a silver lining - Guizhou Zhenhua E-chem is expected to lag the wider industry.

這些估計很有趣,但是在查看預測與貴州振華電子化學過去的表現以及與同一行業的同行進行比較時,可以更粗略地描述一些細節。我們要強調的是,預計銷售將逆轉,預計到2024年底,年化收入將下降7.6%。與過去五年35%的歷史增長相比,這是一個顯著的變化。相比之下,我們的數據表明,在可預見的將來,預計同一行業的其他公司(有分析師報道)的收入每年將增長19%。因此,儘管預計其收入將萎縮,但這種陰雲並沒有帶來一線希望——預計貴州振華電子化學將落後於整個行業。

The Bottom Line

底線

The biggest issue in the new estimates is that analysts have reduced their earnings per share estimates, suggesting business headwinds lay ahead for Guizhou Zhenhua E-chem. Regrettably, they also downgraded their revenue estimates, and the latest forecasts imply the business will grow sales slower than the wider market. With a serious cut to this year's expectations and a falling price target, we wouldn't be surprised if investors were becoming wary of Guizhou Zhenhua E-chem.

新估計中最大的問題是,分析師下調了每股收益預期,這表明貴州振華電子化學面臨業務不利因素。遺憾的是,他們還下調了收入預期,最新的預測表明該業務的銷售增長將慢於整個市場。隨着今年的預期大幅下調和目標股價的下降,如果投資者對貴州振華電子開始保持警惕,我們也不會感到驚訝。

Still, the long-term prospects of the business are much more relevant than next year's earnings. We have estimates - from multiple Guizhou Zhenhua E-chem analysts - going out to 2025, and you can see them free on our platform here.

儘管如此,該業務的長期前景仍比明年的收益更爲重要。我們從多位貴州振華易化分析師那裏獲得了2025年的估計,你可以在我們的平台上免費查看。

Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies that insiders are buying.

尋找可能達到轉折點的有趣公司的另一種方法是使用內部人士收購的成長型公司的免費清單,跟蹤管理層是買入還是賣出。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論